Cargando…
Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis
Multiple candidate biomarkers for amyotrophic lateral sclerosis (ALS) have emerged across a range of platforms. Replication of results, however, has been absent in all but a few cases, and the range of control samples has been limited. If progress toward clinical translation is to continue, the spec...
Autores principales: | Turner, Martin R, Benatar, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270289/ https://www.ncbi.nlm.nih.gov/pubmed/25288265 http://dx.doi.org/10.1002/mus.24470 |
Ejemplares similares
-
Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal
por: Benatar, Michael, et al.
Publicado: (2022) -
Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
por: Dreger, Marie, et al.
Publicado: (2022) -
CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2020) -
A(a)LS: Ammonia-induced amyotrophic lateral sclerosis
por: Parekh, Bhavin
Publicado: (2015) -
The mission to ensure continued funding for excellent basic research
por: Lamond, Angus I., et al.
Publicado: (2023)